Live Breaking News & Updates on Sharvil patel

Stay informed with the latest breaking news from Sharvil patel on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sharvil patel and stay connected to the pulse of your community

Zydus gets China nod for kidney disease drug

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA).

In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus.

CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.

India , China , Taiwan , Macao , Macau-general- , Macau , Sharvil-patel , Zydus-lifesciences , China-medical-system-holdings , Management-ltd , China-medical-system-holdings-ltd , National-medical-products-administration-of-china

Meet man, one of the richest in the world, is India's pharma magnate, his net worth is...

Zydus Lifesciences was cofounded by his late father in 1952 with his business partner Indravadan Modi to make vitamins.

Ahmedabad , Gujarat , India , Udaipur , Orissa , Priti-patel , Zydus-lifesciences , Pankaj-patel , Sharvil-patel , Pankaj-ramanbhai-patel , Pranavd-patel , Cadila-healthcare-ltd

Zydus aims to launch first new drug in US by early 2026

Zydus will enter a competitive field, with an FDA decision on CymaBay's PBC drug due in August. Gilead Sciences announced its acquisition of CymaBay for $4.3 billion earlier in February. Saroglitazar, currently in a mid-to-late-stage trial for PBC, is also being tested for Metabolic Dysfunction-Associated Steatohepatitis (MASH), a type of fatty liver disease."

United-states , India , Ahmedabad , Gujarat , Zydus-lifesciences , Sun-pharma-cipla , Sharvil-patel , Novo-nordisk , Gilead-sciences , Reuters , Managing-director-sharvil-patel , Primary-biliary-cholangitis

BioAsia 2024 begins on Tuesday - The Hindu BusinessLine

BioAsia 2024 begins on Tuesday - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Telangana , Bharat , Jayesh-ranjan , Geoff-martha , Stefan-kaufmann , Neovantage-takshashila , Shakthi-nagappan , Arunish-chawla , Christopher-boerner

Zydus Lifesciences posts Q3 profit rise of 26.8% at Rs 789.60 crore, revenue up 5.8% on-year

Zydus Lifesciences posts Q3 profit rise of 26.8% at Rs 789.60 crore, revenue up 5.8% on-year
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Sharvil-patel , Zydus-lifesciences , Zydus-lifesciences-limited-on , Zydus-lifesciences-limited , Managing-director ,

Zydus Lifesciences net profit jumps 27% in Q3FY24, announced buyback

Zydus Lifesciences on Tuesday reported Rs 789.6 crore net profit in Q3FY24, a year-on-year (YoY) jump of 27% led by growth in India, Europe and emerging market formulation sales.

Ahmedabad , Gujarat , India , Sharvil-patel , Zydus-lifesciences , Zydus-lifesciences-q3-results , Zydus-lifesciences-q3-earnings , Markets-news , Zydus-lifesciences-shares ,

Zydus Lifesciences subsidiary signs licensing agreement with Synthon BV

Zydus Lifesciences subsidiary signs licensing agreement with Synthon BV
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United-states , Anish-mehta , Sharvil-patel , Zydus-lifesciences , Facebook , Zydus-lifesciences-ltd , Twitter , Drug-administration , Linkedin , Zydus-worldwide , United-states-food , Pimavanserin-capsules

Pankaj Patel's Inspirational Journey: From Cadila Laboratories To Owner Of Rs 52,400 Crore Empire | Companies News

Raised in a traditional Patel family, Patel studied at Sheth C. N. Vidyalaya and later earned a Master of Pharmacy degree from L M Pharmacy, Ahmedabad.

Ahmedabad , Gujarat , India , Karamsad , New-delhi , Delhi , Ayodhya , Uttar-pradesh , Pankaj-patel , Sharvil-patel , Rashtriya-vidhyarthi-parishad , Ramanbhai-patel

Why the next decade is India's decade

Zydus Lifesciences chairman and managing director describe how their company is becoming a dominant player in the global healthcare industry.

India , Gautam-kumra , Mckinsey-asia , Sharvil-patel , Pankaj-patel , Zydus-lifesciences , Asia-chairman-gautam-kumra ,

Zydus And Daewoong Pharmaceutical Announces Exclusive Licensing Agreement To Co-develop & Commercialize Leuprolide Acetate

Zydus And Daewoong Pharmaceutical Announces Exclusive Licensing Agreement To Co-develop & Commercialize Leuprolide Acetate
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Osong , Kyongsang-bukto , South-korea , United-states , Sharvil-patel , Zydus-lifesciences-ltd , Zydus-lifesciences-ltd-on , Daewoong-pharmaceutical-co-ltd , Zydus-worldwide , Leuprolide-acetate , Depot-suspension , Lupron-depot